23:00
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
23 views • 6 days ago
31:30
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Set...
9 views • 6 days ago
23:00
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
13 views • 6 days ago
15:00
Evolving Our View of the Coagulation Cascade and Stroke Management
12 views • 7 days ago
10:00
The Value of CINtec® PLUS Cytology Test in Cervical Cancer Screening
54 views • 6 days ago
14:00
Consensus Recommendations for Use of p16/Ki67 Dual Staining Cytology in the Management of Individ...
18 views • 7 days ago
13:30
Poster Pearl: A 2-Biomarker Class MCED Test Delivers High Specificity and Sensitivity
4 views • 8 days ago
15:00
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
14 views • 9 days ago
16:30
Diagnostic and Treatment Dilemmas in Polymyalgia Rheumatica
40 views • 2 weeks ago
16:30
Diagnostic and Treatment Dilemmas in Polymyalgia Rheumatica
25 views • 2 weeks ago
10:30
Elderly Patients with IBD: Management Strategies and Care
33 views • 2 weeks ago
23:30
Investigating HLH: Our Current Understanding of a Rare Disease
33 views • 3 weeks ago
5:30
Optimizing Consolidative Immunotherapy in Unresectable Stage III NSCLC: Case Discussion
18 views • 3 weeks ago
6:00
Differentiating and Managing Pneumonitis in Unresectable Stage III NSCLC: Case Discussion
18 views • 3 weeks ago
6:00
Immunotherapy Approaches in Unresectable Stage III NSCLC: What’s on the Horizon?
14 views • 3 weeks ago
4:30
Consolidative Immunotherapy in Unresectable Stage III NSCLC With Oncogenic Drivers
9 views • 3 weeks ago
4:30
Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC
14 views • 3 weeks ago
5:30
Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?
6 views • 3 weeks ago
4:00
Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?
15 views • 3 weeks ago
5:00
Accurate Staging and Determining Resectability in NSCLC
14 views • 3 weeks ago
5:30
Resolving Practice Barriers to Consolidative Immunotherapy in Stage III NSCLC
12 views • 3 weeks ago
5:30
Initial BTK Inhibitor-Based Treatment Selection in a Treatment-Naive, Symptomatic, Unfit Older Pa...
18 views • 3 weeks ago
5:30
Safety and Tolerability of Changing Covalent BTK Inhibitor Treatment in a Patient Intolerant to I...
16 views • 3 weeks ago
5:30
Selection of BTK Inhibitor Following Frontline Chemoimmunotherapy in Older Patients With Comorbid...
14 views • 3 weeks ago
9:00
Partners in Medicine: A Married Couple's Adventure in Locum Tenens
7 views • 3 weeks ago
5:00
Keys to Maneuvering Discrepancies in Clinical Practice Guidelines
3 views • 2 weeks ago
5:30
Considerations for Using Opioids and Cannabis to Treat Chronic Pain
7 views • 2 weeks ago
5:00
Keys to Maneuvering Discrepancies in Clinical Practice Guidelines
8 views • 3 weeks ago
5:30
Considerations for Using Opioids and Cannabis to Treat Chronic Pain
10 views • 3 weeks ago
4:30
Managing Osteoporosis: How to Create Personalized Treatment Plans
16 views • 2 weeks ago
Load More